Because the mechanism(s) underlying the change in HRD1 solubility are unclear, we have investigated the possible roles of AD-related molecules and stresses, such as Aβ, tau, ER stress, and oxidative stress. The gene discussed is MAPT; the disease is Alzheimer disease.